ArticleThe Journal of clinical investigation2022

Cross-talk between HIF and PD-1/PD-L1 pathways in carcinogenesis and therapy.

Michael R Shurin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.